Glycoproteomic characterization of recombinant mouse -dystroglycan

Glycobiology

Volumn 22, Issue 5, 2012, Pages 662-675

  Harrison, Rebecca ^a   Hitchen, Paul G ^a   Panico, Maria ^a   Morris, Howard R ^a   Mekhaiel, David ^b   Pleass, Richard J ^b   Dell, Anne ^a   Hewitt, Jane E ^b   Haslam, Stuart M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Dystroglycan; glycoproteomics; mass spectrometry; O GalNAc; O mannose

Indexed keywords

ALPHA DYSTROGLYCAN; GLYCAN DERIVATIVE; GLYCOPEPTIDE; GLYCOPROTEIN; MANNOSE; N ACETYLGALACTOSAMINE; RECOMBINANT ALPHA DYSTROGLYCAN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; GLYCOPROTEOMICS; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; PROTEOMICS; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CHROMATOGRAPHY, LIQUID; DYSTROGLYCANS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTEOMICS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84859046698     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws002     Document Type: Article

References (46)

1. Akasaka-Manya K, Manya H, Nakajima A, Kawakita M, Endo T. 2006. Physical and functional association of human protein O-mannosyltransferases 1 and 2. J Biol Chem. 281:19339-19345
2. Andac Z, Sasaki T, Mann K, Brancaccio A, Deutzmann R, Timpl R. 1999. Analysis of heparin, alpha-dystroglycan and sulfatide binding to the G domain of the laminin alpha1 chain by site-directed mutagenesis. J Mol Biol. 287:253-264
3. Barresi R, Campbell KP. 2006. Dystroglycan: From biosynthesis to pathogenesis of human disease. J Cell Sci. 119:199-207
4. Blake DJ, Weir A, Newey SE, Davies KE. 2002. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev. 82:291-329
5. Breloy I, Schwientek T, Gries B, Razawi H, Macht M, Albers C, Hanisch FG. 2008. Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the α-dystroglycan mucin domain. J Biol Chem. 283:18832-18840
6. Brown SC, Torelli S, Brockington M, Yuva Y, Jimenez C, Feng L, Anderson L, Ugo I, Kroger S, Bushby K, et al. 2004. Abnormalities in α-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. Am J Pathol. 164:727-737
7. Chiba A, Matsumura K, Yamada H, Inazu T, Shimizu T, Kusunoki S, Kanazawa I, Kobata A, Endo T. 1997. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin. J Biol Chem. 272:2156-2162
8. Combs AC, Ervasti JM. 2005. Enhanced laminin binding by α-dystroglycan after enzymatic deglycosylation. Biochem J. 390:303-309
9. Durbeej M, Campbell KP. 1999. Biochemical characterization of the epithelial dystroglycan complex. J Biol Chem. 274:26609-26616
10. Durbeej M, Henry MD, Campbell KP. 1998. Dystroglycan in development and disease. Curr Opin Cell Biol. 10:594-601
11. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P. 1998. Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem. 46:449-457
12. Durbeej M, Larsson E, Ibraghimov-Beskrovnaya O, Roberds SL, Campbell KP, Ekblom P. 1995. Non-muscle alpha-dystroglycan is involved in epithelial development. J Cell Biol. 130:79-91
13. Ervasti JM, Burwell AL, Geissler AL. 1997. Tissue-specific heterogeneity in α-dystroglycan sialoglycosylation. Skeletal muscle α-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification. J Biol Chem. 272:22315-22321
14. Ervasti JM, Campbell KP. 1991. Membrane organization of the dystrophinglycoprotein complex. Cell. 66:1121-1131
15. Ervasti JM, Campbell KP. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 122:809-823
16. Gee SH, Montanaro F, Lindenbaum MH, Carbonetto S. 1994. Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell. 77:675-686
17. Godfrey C, Clement E, Mein R, Brockington M, Smith J, Talim B, Straub V, Robb S, Quinlivan R, Feng L, et al. 2007. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain. 130:2725-2735
18. Hewitt JE. 2009. Abnormal glycosylation of dystroglycan in human genetic disease. Biochim Biophys Acta. 1792:853-861
19. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355:696-702
20. Ismail MN, Stone EL, Panico M, Lee SH, Luu Y, Ramirez K, Ho SB, Fukuda M, Marth JD, Haslam SM, et al. 2011. High-sensitivity O-glycomic analysis of mice deficient in core 2 β1,6-N-acetylglucosaminyltransferases. Glycobiology. 21:82-98
21. Jensen PH, Kolarich D, Packer NH. 2009. Mucin-type O-glycosylation - putting the pieces together. FEBS J. 277:81-94
22. Jones MD, Merewether LA, Clogston CL, Lu HS. 1994. Peptide map analysis of recombinant human granulocyte colony stimulating factor: Elimination of methionine modification and nonspecific cleavages. Anal Biochem. 216:135-146
23. Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB. 2001. Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan. J Cell Biol. 155:301-310
24. Liu J, Ball SL, Yang Y, Mei P, Zhang L, Shi H, Kaminski HJ, Lemmon VP, Hu H. 2006. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1). Mech Dev. 123:228-240
25. Lommel M, Willer T, Strahl S. 2008. POMT2, a key enzyme in Walker- Warburg syndrome: Somatic sPOMT2, but not testis-specific tPOMT2, is crucial for mannosyltransferase activity in vivo. Glycobiology. 18:615-625
26. Manya H, Suzuki T, Akasaka-Manya K, Ishida HK, Mizuno M, Suzuki Y, Inazu T, Dohmae N, Endo T. 2007. Regulation of mammalian protein O-mannosylation: Preferential amino acid sequence for O-mannose modification. J Biol Chem. 282:20200-20206
27. Miyagoe-Suzuki Y, Masubuchi N, Miyamoto K, Wada MR, Yuasa S, Saito F, Matsumura K, Kanesaki H, Kudo A, Manya H, et al. 2009. Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro. Mech Dev. 126:107-116
28. Muntoni F, Brockington M, Blake DJ, Torelli S, Brown SC. 2002. Defective glycosylation in muscular dystrophy. Lancet. 360:1419-1421
29. Muntoni F, Brockington M, Torelli S, Brown SC. 2004. Defective glycosylation in congenital muscular dystrophies. Curr Opin Neurol. 17:205-209
30. Nakamura N, Stalnaker SH, Lyalin D, Lavrova O, Wells L, Panin VM. 2010. Drosophila dystroglycan is a target of O-mannosyltransferase activity of two protein O-mannosyltransferases, Rotated Abdomen and Twisted. Glycobiology. 20:381-394
31. Nilsson J, Larson G, Grahn A. 2010. Characterization of site-specific O-glycan structures within the mucin-like domain of α-dystroglycan from human skeletal muscle. Glycobiology. 20:1160-1169
32. Parry S, Ledger V, Tissot B, Haslam SM, Scott J, Morris HR, Dell A. 2007. Integrated mass spectrometric strategy for characterizing the glycans from glycosphingolipids and glycoproteins: Direct identification of sialyl Lex in mice. Glycobiology. 17:646-654
33. Patnaik SK, Stanley P. 2005. Mouse large can modify complex N- and mucin O-glycans on α-dystroglycan to induce laminin binding. J Biol Chem. 280:20851-20859
34. Perrine CL, Ganguli A, Wu P, Bertozzi CR, Fritz TA, Raman J, Tabak LA, Gerken TA. 2009. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2. J Biol Chem. 284:20387-20397
35. Sasaki T, Yamada H, Matsumura K, Shimizu T, Kobata A, Endo T. 1998. Detection of O-mannosyl glycans in rabbit skeletal muscle α-dystroglycan. Biochim Biophys Acta. 1425:599-606
36. Smalheiser NR, Haslam SM, Sutton-Smith M, Morris HR, Dell A. 1998. Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J Biol Chem. 273:23698-23703
37. Stalnaker SH, Hashmi S, Lim JM, Aoki K, Porterfield M, Gutierrez- Sanchez G, Wheeler J, Ervasti JM, Bergmann C, Tiemeyer M, et al. 2010. Site mapping and characterization of O-glycan structures on α-dystroglycan isolated from rabbit skeletal muscle. J Biol Chem. 285:24882-24891
38. Stalnaker SH, Kazuhiro A, Lim JM, Porterfield M, Liu M, Satz JS, Buskirk S, Xiong Y, Zhang P, Campbell KP, et al. 2011. Glycomic analyses of mouse models of congenital muscular dystrophy. J Biol Chem. 288:201180-201190
39. Sugita S, Saito F, Tang J, Satz J, Campbell K, Sudhof TC. 2001. A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol. 154:435-445
40. Sugiyama J, Bowen DC, Hall ZW. 1994. Dystroglycan binds nerve and muscle agrin. Neuron. 13:103-115
41. Talts JF, Andac Z, Gohring W, Brancaccio A, Timpl R. 1999. Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMBO J. 18:863-870
42. Torres BV, McCrumb DK, Smith DF. 1988. Glycolipid-lectin interactions: Reactivity of lectins from Helix pomatia, Wisteria floribunda, and Dolichos biflorus with glycolipids containing N-acetylgalactosamine. Arch Biochem Biophys. 262:1-11
43. Wizemann H, Garbe JH, Friedrich MV, Timpl R, Sasaki T, Hohenester E. 2003. Distinct requirements for heparin and α-dystroglycan binding revealed by structure-based mutagenesis of the laminin α2 LG4-LG5 domain pair. J Mol Biol. 332:635-642
44. Wopereis S, Lefeber DJ, Morava E, Wevers RA. 2006. Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: A review. Clin Chem. 52: 574-600
45. Yoshida A, Kobayashi K, Manya H, Taniguchi K, Kano H, Mizuno M, Inazu T, Mitsuhashi H, Takahashi S, Takeuchi M, et al. 2001. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell. 1:717-724
46. Yoshida-Moriguchi T, Yu L, Stalnaker SH, Davis S, Kunz S, Madson M, Oldstone MB, Schachter H, Wells L, Campbell KP. 2010. O-Mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science. 327:88-92.